Response Genetics, Inc. to Release Third Quarter 2008 Financial Results and Present at the Rodman & Renshaw Tenth Annual Healthcare Conference

November 6, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce third quarter 2008 financial results Friday, November 7 after close of market.

Twitter
LinkedIn
Facebook
Email
Print